Fuentevilla, Jayril Love T.
HRN: 25-71-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2024
AMPICILLIN 250MG (VIAL)
08/18/2024
08/25/2024
IV
250mg
Q6H
URTI
Waiting Final Action
Indication: Prophylaxis Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes